AbelZeta
AbelZeta
Group: Spacebears
Discovered by ransomware.live: 2026-03-12
Estimated attack date: 2026-03-10
Country:
Description:
AbelZeta Pharma is a global cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies, inflammatory and immunological diseases and solid tumors.Partners: AstraZeneca, Janssen (J&J), NovartisInvestors: HSG, Yunfeng Capital, GIC, TF Capital, CICC Capital, Sailing Capital, Dangdai Group, AstraZeneca-CICC Fund170,000+ different files670+ separate archives with experiments on various candidates All studies: CAR032, CAR39, CAR66, CAR168, TIL, CD, Tcell, etc. There are a huge number of files and studies, all of which are confidential and valuable for competitive research. https://www.abelzeta.com/
DNS Records:
The following DNS records were found for the victim's domain.
- DomainAbuse@service.aliyun.com
- abelzeta-com.mail.protection.outlook.com.
- ms90891867
- v=spf1 include:spf.protection.outlook.com include:sendarid.net include:spf.mandrilapp.com ip4:58.33.83.114 ~all
- ZOOM_verify_BrF1d7mreg4aAuVXx7B1ij
- ZOOM_verify_YEFDdVxYPxInanFoLAzNgw
Leak Screenshot:
Legal Disclaimer: Ransomware.live does not engage in the acquisition, exfiltration, downloading, possession, hosting, access, consultation, redistribution, or disclosure of unlawfully obtained data. This platform indexes only publicly visible information posted by ransomware operators and open web sources without accessing or obtaining the underlying stolen content. The service is provided to support public awareness, legitimate research, and cyber-resilience. No stolen personal or confidential data is collected or distributed via this site.